Amy E. DeZern
- Hematology top 0.2%
- Acute Myeloid Leukemia Research 129
- Hematopoietic Stem Cell Transplantation 50
- Chronic Myeloid Leukemia Treatments 27
- Genetics top 1%
- Myeloproliferative Neoplasms: Diagnosis and Treatment 54
- Chronic Lymphocytic Leukemia Research 14
- Immunology top 5%
- Immunodeficiency and Autoimmune Disorders 14
- Transplantation top 5%
- Nephrology top 5%
-
- Acute Lymphoblastic Leukemia research 30
-
- Histone Deacetylase Inhibitors Research 15
- Co-authors
- Robert A. BrodskyTaroh KinoshitaAnita HillRichard J. JonesLukasz P. GondekDavid P. SteensmaMikkael A. SekeresGuillermo Garcia‐Manero
- Cited by
- HematologyGeneticsImmunology
- Journals
- Blood (70 papers)Blood Advances (8 papers)Biology of Blood and Marrow Transplantation (8 papers)
- Partner nations
- United StatesCanadaItaly
In The Last Decade
Amy E. DeZern
185 papers receiving 3.6k citations
Peers
Comparison fields: 5 of 112
- Hematology 2.4k
- Genetics 985
- Immunology 864
- Transplantation 86
- Nephrology 211
Countries citing papers authored by Amy E. DeZern
This map shows the geographic impact of Amy E. DeZern's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy E. DeZern with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy E. DeZern more than expected).
Fields of papers citing papers by Amy E. DeZern
This network shows the impact of papers produced by Amy E. DeZern. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy E. DeZern. The network helps show where Amy E. DeZern may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Amy E. DeZern, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 5 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 4 | |
| 6 | 2023 | 18 | |
| 7 | 2022 | 1 | |
| 8 | 2022 | 6 | |
| 9 | 2021 | 53 | |
| 10 | 2021 | 1 | |
| 11 | 2021 | 10 | |
| 12 | 2021 | 20 | |
| 13 | 2020 | 1 | |
| 14 | 2019 | 26 | |
| 15 | 2018 | 144 | |
| 16 | 2018 | 74 | |
| 17 | 2018 | 3 | |
| 18 | 2016 | 62 | |
| 19 | 2015 | 23 | |
| 20 | 2015 | 2 |
About Amy E. DeZern
Amy E. DeZern is a scholar working on Hematology, Genetics, Transplantation, Immunology and Oncology, having authored 202 papers that have together received 3.7k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (129 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (54 papers), Hematopoietic Stem Cell Transplantation (50 papers), Acute Lymphoblastic Leukemia research (30 papers), Chronic Myeloid Leukemia Treatments (27 papers), Histone Deacetylase Inhibitors Research (15 papers), Chronic Lymphocytic Leukemia Research (14 papers) and Immunodeficiency and Autoimmune Disorders (14 papers). The work is most often cited by research in Hematology (2.4k citations), Genetics (985 citations), Immunology (864 citations), Transplantation (86 citations) and Nephrology (211 citations). Amy E. DeZern has collaborated with scholars based in United States, Canada and Italy. Frequent co-authors include Robert A. Brodsky, Taroh Kinoshita, Anita Hill, Richard J. Jones, Lukasz P. Gondek, David P. Steensma, Mikkael A. Sekeres, Guillermo Garcia‐Manero, Gail J. Roboz and Mary Armanios. Their work appears in journals such as Blood, Blood Advances, Biology of Blood and Marrow Transplantation, Journal of Clinical Oncology and Transplantation and Cellular Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.